Compare Dolby Laboratories, Inc. (DLB) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Ulta Beauty Inc — how do they compare? Dolby Laboratories, Inc. trades at $58.45 (market cap $5.47B), while Ulta Beauty Inc trades at $562.39 (market cap $23.32B). The key difference: Ulta Beauty Inc is far larger — about 4.3× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.47% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Ulta Beauty Inc for 92 Days on average.
| DLB | ULTA | |
|---|---|---|
Market Cap | $5.47B | $23.32B |
Volume | 691,016 | 321,683 |
Sector | Technology | Consumer Cyclical |
52-Week High | $70.09 | $706.82 |
52-Week Low | $48.51 | $450.75 |
Typical Hold Time | 98 Days | 92 Days |
Enterprise Value | $4.84B | $25.63B |
Dividend Yield | 2.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.
DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.
ULTA trades at $564.21, up 3.09% today, with a bullish technical outlook and strong analyst support. The stock has shown robust earnings beats in recent quarters, with Q1 and Q2 2026 exceeding expectations, and the company raised its 2026 guidance. Revenue growth is steady, though net margins have softened slightly from 12.17% in 2023 to 10.63% in 2025. Valuation ratios like a P/E of 19.86 and P/S of 1.86 appear reasonable relative to profitability metrics such as a 46.12% ROE.
The investment case hinges on execution of raised guidance and e-commerce momentum, but risks include margin pressure and flat store traffic. With a consensus price target of $624.93 implying ~11% upside and no sell ratings from analysts, the stock presents a growth opportunity tempered by near-term consumer and competitive challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
